omidubicel

Gamida lays off 17%, ditches NK cell therapy work to keep blood cancer drug on track
Fierce Biotech
Mon, 03/27/23 - 09:55 am
Gamida Cell
layoffs
omidubicel
natural killer cells
FDA pushes back Gamida Cell’s PDUFA date by three months
Endpoints
Sun, 11/27/22 - 07:12 pm
Gamida Cell
PDUFA
FDA
omidubicel
Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers
Businesswire
Thu, 09/29/22 - 09:59 am
Gamida Cell
solid tumors
blood cancers
omidubicel
Novartis-backed Gamida hits goal in phase 3 cancer trial
Fierce Biotech
Tue, 05/12/20 - 12:04 pm
Gamida Cell
Novartis
omidubicel
blood cancer
clinical trials